CLASSIFICATION: BODY PROTECTING COMPOUND
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER)
ACTIVE HALF-LIFE: ~ 4-6 HOURS
DOSAGE: 200-500 MCG/DAY
MANUFACTURER: AXIOLABS
Axiolabs BPC 157 5 mg is a synthetic pentadecapeptide derived from a protective protein found in the stomach. This research compound has gained attention for its potential role in accelerating healing of tendons, ligaments, and soft tissues. Each 2 mL vial contains 5 mg of lyophilized BPC 157, ready for reconstitution with bacteriostatic water for laboratory studies.
Bodybuilders and athletes interested in recovery research often turn to BPC 157 due to its proposed regenerative properties. Unlike anabolic steroids, this peptide works through localized and systemic pathways to support tissue repair, making it a unique subject for performance-related studies. For similar research products, explore TB 500 5 mg or GHK-CU 50 mg.
Compared to other research peptides, Axiolabs BPC 157 offers a stable lyophilized format that maintains peptide integrity during transport and storage. The pentadecapeptide sequence is identical to the naturally occurring fragment, which is why researchers favor it for studies involving angiogenesis, tendon-to-bone healing, and gastrointestinal cytoprotection.
For those investigating recovery acceleration, this peptide is often compared to growth hormone secretagogues like Ipamorelin 5 mg. However, BPC 157 works through different mechanisms, primarily by promoting the formation of new blood vessels and modulating growth factor expression.
Axiolabs BPC 157 is intended for laboratory research only. Not for human consumption or clinical use.
External research on BPC 157's mechanisms can be explored via PubMed for peer-reviewed studies.
For laboratory research use only. Not for human consumption. Reconstitution and handling must be performed by qualified personnel using sterile techniques.
The standard reconstitution yields a concentration of approximately 1.67-2.5 mg/mL. For precise dosing, researchers should calculate based on desired mcg per injection volume.
In animal models and in vitro studies, BPC 157 is often administered at dosages ranging from 250 mcg to 500 mcg per day. For injectable research, subcutaneous administration near the site of injury is common. Oral administration studies have also been conducted using the stable pentadecapeptide.
BPC 157 is frequently studied alongside TB-500 for synergistic effects on soft tissue repair. For stacking in research protocols, TB 500 5 mg can be reconstituted and administered on alternating days.
Note: Dosages mentioned are for research purposes only. Individual response varies in animal models. Always follow institutional animal care guidelines when conducting in vivo research.
Third-party analytical testing (COA) for Axiolabs BPC 157 5 mg is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.
This product is supplied through the official Axiolabs distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Store Axiolabs BPC 157 5 mg lyophilized powder in a cool, dry place away from direct light and moisture. Prior to reconstitution, the unopened vial should be kept at controlled room temperature (15-25°C) or refrigerated (2-8°C) for long-term storage. Do not freeze the lyophilized powder, as this may damage the peptide structure.
After reconstitution with bacteriostatic water, the solution must be stored at 2-8°C (refrigerator) and used within 30 days to maintain peptide integrity. Avoid repeated freeze-thaw cycles. Do not use if the solution appears cloudy or contains particulates, or if the vial seal is compromised.
Keep out of reach of children and unauthorized personnel. Follow standard laboratory safety protocols when handling peptides.
Proper storage conditions help maintain research-grade purity and consistent performance across the product's shelf life.
BPC 157 is studied for its potential to accelerate tendon, ligament, and soft tissue healing in animal models. Researchers also investigate its gastroprotective and anti-inflammatory properties.
Add 2-3 mL of bacteriostatic water to the 5 mg vial, swirling gently until fully dissolved. The resulting concentration will be approximately 1.67-2.5 mg/mL depending on the volume used.
In animal studies, dosages often range from 250 mcg to 500 mcg per day, administered subcutaneously or orally. Higher dosages may be used for oral research due to lower bioavailability.
Yes. BPC 157 is commonly studied alongside TB-500 for synergistic soft tissue repair. It may also be combined with GHK-CU or Ipamorelin in comprehensive research protocols.
Third-party COA testing is currently pending. Axiolabs is committed to publishing batch-specific lab reports as soon as analytical testing is completed and verified.
Please log in to write BPC 157 5 MG review.
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: NOT APPLICABLE
DOSAGE: 250–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: BODY PROTECTING COMPOUND
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER)
ACTIVE HALF-LIFE: ~ 4-6 HOURS
DOSAGE: 200-500 MCG/DAY
ACNE: NOT REPORTED
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO KNOWN IMPACT
HEPATOTOXICITY: NONE
AROMATIZATION: DOES NOT AROMATIZE
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: PEPTIDE / CYTOPROTECTIVE AGENT
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER)
ACTIVE HALF-LIFE: N/A
DOSAGE: 200–500 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
CLASSIFICATION: REGENERATIVE PEPTIDE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER)
ACTIVE HALF-LIFE: ~ 4–6 HOURS
DOSAGE: 200–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: GROWTH HORMONE ANALOG
ACTIVE SUBSTANCE: SOMATROPIN (R-HGH)
FORM: 1 KIT [10 X 10 ML VIALS] x 20 IU
ACTIVE HALF-LIFE: 2.5-3 DAYS
DOSAGE: MEN 4-10 IU/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS